News

Year: 
2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001
12/15/2005 The Wistar Institute Sells Partial Royalty Interest in Merck’s ROTATEQ® to the Paul Royalty Fund
11/4/2005 “Drug Makers Look to Revenue Interest Financing for a Flexible, Healthy Cash Infusion” (pdf)
6/9/2005 Verus Pharmaceuticals Announces $98 Million Financing
5/18/2005 AVANT Monetizes Royalty Stream from Rotarix Through Transaction with Paul Royalty Fund

© 2010 by Paul Capital. All rights reserved.